Literature DB >> 11729039

Venlafaxine- and trazodone-induced serotonin syndrome.

R E McCue, M Joseph.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11729039     DOI: 10.1176/appi.ajp.158.12.2088

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

Review 2.  Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors:  J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2010-11-04       Impact factor: 2.007

Review 3.  Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.

Authors:  Claire Rampon; Bruno P Guiard; Basile Coutens; Antoine Yrondi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-10       Impact factor: 4.415

4.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

5.  Arrhythmias in Severe Trazodone Overdose.

Authors:  Kyaw Khaing Soe; Mark Young Lee
Journal:  Am J Case Rep       Date:  2019-12-27

Review 6.  Drug-Induced Hyperthermia Review.

Authors:  Michael Horseman; Ladan Panahi; George Udeani; Andrew S Tenpas; Rene Verduzco; Pooja H Patel; Daniela Z Bazan; Andrea Mora; Nephy Samuel; Anne-Cecile Mingle; Lisa R Leon; Joseph Varon; Salim Surani
Journal:  Cureus       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.